105 related articles for article (PubMed ID: 15817638)
1. Beta2-adrenoceptor regulation of the K+ channel iKCa1 in human mast cells.
Duffy SM; Cruse G; Lawley WJ; Bradding P
FASEB J; 2005 Jun; 19(8):1006-8. PubMed ID: 15817638
[TBL] [Abstract][Full Text] [Related]
2. The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells.
Mark Duffy S; Berger P; Cruse G; Yang W; Bolton SJ; Bradding P
J Allergy Clin Immunol; 2004 Jul; 114(1):66-72. PubMed ID: 15241346
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells.
Wang XS; Lau HY
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):746-50. PubMed ID: 16895550
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.
Chong LK; Suvarna K; Chess-Williams R; Peachell PT
Br J Pharmacol; 2003 Feb; 138(3):512-20. PubMed ID: 12569076
[TBL] [Abstract][Full Text] [Related]
5. The effects of S1319, a novel marine sponge-derived beta2-adrenoceptor agonist, on IgE-mediated activation of human cultured mast cells.
Suzuki H; Ueno A; Takei M; Shindo K; Higa T; Fukamachi H
Inflamm Res; 2000 Feb; 49(2):86-94. PubMed ID: 10738947
[TBL] [Abstract][Full Text] [Related]
6. Influence of receptor reserve on beta-adrenoceptor-mediated responses in human lung mast cells.
Drury DE; Chong LK; Ghahramani P; Peachell PT
Br J Pharmacol; 1998 Jun; 124(4):711-8. PubMed ID: 9690863
[TBL] [Abstract][Full Text] [Related]
7. Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.
Duffy SM; Cruse G; Brightling CE; Bradding P
Eur J Immunol; 2007 Jun; 37(6):1653-62. PubMed ID: 17474152
[TBL] [Abstract][Full Text] [Related]
8. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells.
Tsuji T; Kato T; Kimata M; Miura T; Serizawa I; Inagaki N; Nagai H
Biol Pharm Bull; 2004 Oct; 27(10):1549-54. PubMed ID: 15467193
[TBL] [Abstract][Full Text] [Related]
10. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
[TBL] [Abstract][Full Text] [Related]
11. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
Chong LK; Cooper E; Vardey CJ; Peachell PT
Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
[TBL] [Abstract][Full Text] [Related]
12. cAMP-independent mechanism is significantly involved in beta2-adrenoceptor-mediated tracheal relaxation.
Koike K; Yamashita Y; Horinouchi T; Yamaki F; Tanaka Y
Eur J Pharmacol; 2004 May; 492(1):65-70. PubMed ID: 15145708
[TBL] [Abstract][Full Text] [Related]
13. Influence of agonist intrinsic activity on the desensitisation of beta2-adrenoceptor-mediated responses in mast cells.
Scola AM; Chong LK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Sep; 143(1):71-80. PubMed ID: 15289287
[TBL] [Abstract][Full Text] [Related]
14. Methylglyoxal Impairs β
Akagawa M; Mori A; Sakamoto K; Nakahara T
Biol Pharm Bull; 2018; 41(2):272-276. PubMed ID: 29386487
[TBL] [Abstract][Full Text] [Related]
15. Counterregulation of beta(2)-adrenoceptor function in human mast cells by stem cell factor.
Cruse G; Yang W; Duffy SM; Chachi L; Leyland M; Amrani Y; Bradding P
J Allergy Clin Immunol; 2010 Jan; 125(1):257-63.e1-5. PubMed ID: 19864009
[TBL] [Abstract][Full Text] [Related]
16. The role of potassium channels in the inhibitory effects of beta 2-adrenoceptor agonists on DNA synthesis in human cultured airway smooth muscle.
Gillzan KM; Stewart AG
Pulm Pharmacol Ther; 1997; 10(2):71-9. PubMed ID: 9425638
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods.
Hanratty CG; Silke B; Riddell JG
Br J Clin Pharmacol; 1999 Feb; 47(2):157-66. PubMed ID: 10190650
[TBL] [Abstract][Full Text] [Related]
18. Beta 2-adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: importance of the duration of beta 2-adrenoceptor stimulation.
Stewart AG; Tomlinson PR; Wilson JW
Br J Pharmacol; 1997 Jun; 121(3):361-8. PubMed ID: 9179374
[TBL] [Abstract][Full Text] [Related]
19. Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration.
Duffy SM; Cruse G; Cockerill SL; Brightling CE; Bradding P
Eur J Immunol; 2008 Sep; 38(9):2548-56. PubMed ID: 18792407
[TBL] [Abstract][Full Text] [Related]
20. Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
Juergens UR; Stöber M; Libertus H; Darlath W; Gillissen A; Vetter H
Eur J Med Res; 2004 Jul; 9(7):365-70. PubMed ID: 15337638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
